Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Lang

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Lancet (London, England)|April 2, 2013
Efficacy of tetravalent dengue vaccine in Thai schoolchildren - Authors' replyArunee Sabchareon, Derek Wallace, Jean Lang, et al.
Vaccine|October 18, 2015
Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forwardBruno Guy, Olivier Briand, Jean Lang, et al.
The American Journal of Tropical Medicine and Hygiene|October 7, 2011
Priming effect of dengue and yellow fever vaccination on the immunogenicity, infectivity, and safety of a tetravalent dengue vaccine in humansMing Qiao, David Shaw, Remi Forrat, et al.
Viruses|December 20, 2013
Preclinical and clinical development of a YFV 17 D-based chimeric vaccine against West Nile virusGustavo H Dayan, Konstantin Pugachev, Joan Bevilacqua, et al.
The Pediatric Infectious Disease Journal|November 3, 2010
Live-attenuated Tetravalent Dengue Vaccine in Dengue-naïve Children, Adolescents, and Adults in Mexico City: Randomized Controlled Phase 1 Trial of Safety and ImmunogenicityJorge Poo, Francisco Galan, Remi Forrat, et al.
Vaccine|November 15, 2003
Efficacy of rabies immunoglobulins in an experimental post-exposure prophylaxis rodent modelAlexandre Servat, Charles Lutsch, Valentine Delore, et al.
Vaccine|July 13, 2011
From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccineBruno Guy, Beatrice Barrere, Claire Malinowski, et al.
Vaccine|October 8, 2009
Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis virusesBruno Guy, Farshad Guirakhoo, Veronique Barban, et al.
Microbes and Infection|May 16, 2006
Host-cell interaction of attenuated and wild-type strains of yellow fever virus can be differentiated at early stages of hepatocyte infectionAnabelle Lefeuvre, Hugues Contamin, Thierry Decelle, et al.
The Journal of Infectious Diseases|January 12, 2010
A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adultsDennis Morrison, Thomas J Legg, Christopher W Billings, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Lancet (London, England)|April 2, 2013
Efficacy of tetravalent dengue vaccine in Thai schoolchildren - Authors' replyArunee Sabchareon, Derek Wallace, Jean Lang, et al.
Vaccine|October 18, 2015
Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forwardBruno Guy, Olivier Briand, Jean Lang, et al.
The American Journal of Tropical Medicine and Hygiene|October 7, 2011
Priming effect of dengue and yellow fever vaccination on the immunogenicity, infectivity, and safety of a tetravalent dengue vaccine in humansMing Qiao, David Shaw, Remi Forrat, et al.
Viruses|December 20, 2013
Preclinical and clinical development of a YFV 17 D-based chimeric vaccine against West Nile virusGustavo H Dayan, Konstantin Pugachev, Joan Bevilacqua, et al.
The Pediatric Infectious Disease Journal|November 3, 2010
Live-attenuated Tetravalent Dengue Vaccine in Dengue-naïve Children, Adolescents, and Adults in Mexico City: Randomized Controlled Phase 1 Trial of Safety and ImmunogenicityJorge Poo, Francisco Galan, Remi Forrat, et al.
Vaccine|November 15, 2003
Efficacy of rabies immunoglobulins in an experimental post-exposure prophylaxis rodent modelAlexandre Servat, Charles Lutsch, Valentine Delore, et al.
Vaccine|July 13, 2011
From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccineBruno Guy, Beatrice Barrere, Claire Malinowski, et al.
Vaccine|October 8, 2009
Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis virusesBruno Guy, Farshad Guirakhoo, Veronique Barban, et al.
Microbes and Infection|May 16, 2006
Host-cell interaction of attenuated and wild-type strains of yellow fever virus can be differentiated at early stages of hepatocyte infectionAnabelle Lefeuvre, Hugues Contamin, Thierry Decelle, et al.
The Journal of Infectious Diseases|January 12, 2010
A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adultsDennis Morrison, Thomas J Legg, Christopher W Billings, et al.
Pageof 6